Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Therapeutics|May 21, 2009
Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarinJules I Schwartz, Fang Liu, Mark Stroh, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2016
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activitiesDan Lu, Tong Lu, Mark Stroh, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 7, 2013
Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humansChristopher R Gibson, Ping Lu, Cheri Maciolek, et al.
Cardiovascular Therapeutics|November 12, 2009
Effects of laropiprant, a selective prostaglandin D(2) receptor 1 antagonist, on the pharmacokinetics of rosiglitazoneJules I Schwartz, Mark Stroh, Bing Gao, et al.
American Journal of Therapeutics|December 23, 2009
A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteersWaldemar Radziszewski, Eseng Lai, Nicole Lazarus Shipitofsky, et al.
American Journal of Therapeutics|December 23, 2009
The effects of multiple doses of rolofylline on the single-dose pharmacokinetics of midazolam in healthy subjectsMark Stroh, Victor Dishy, Waldemar Radziszewski, et al.
Cancer Chemotherapy and Pharmacology|June 7, 2012
The minimal impact of food on the pharmacokinetics of ridaforolimusMark Stroh, Xiaodong Li, Sabrina Marsilio, et al.
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor KineticsLaurent Claret, Jin Y Jin, Charles Ferté, et al.
The AAPS Journal|February 10, 2009
Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse eventMark Stroh, Carol Addy, Yunhui Wu, et al.
Pageof 4